1 Min Read
Okava Pharmaceuticals, a clinical-stage company developing medicines for cats and dogs, announced a new clinical trial testing a GLP-1 implant for cats on Tuesday. The trial is appropriately named MEOW-1 (ManagEment of Over Weight cats). OKV-119 is Okava’s long-release GLP-1 implant, designed to slowly release the drug over six months. The implant is from Vivani… The post Does your cat need Ozempic? GLP-1s in veterinary medicine appeared first on Drug Discovery and Development.
Work & Theory on December 5, 2025
Uncategorized